Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | PARL | Q9H300 | 1/20 | 0.31 |
| ▸ | PRKCA | P17252 | 5/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27798404 | 0.95 | KMT2A (0.33) | SMN1; SMN2KMT2APARL | |
| SCHEMBL28063863 | 0.94 | TSHR (0.38) | SMN1; SMN2KMT2AGAAALDH1A1 | |
| SCHEMBL28176590 | 0.92 | KMT2A (0.49) | SMN1; SMN2KMT2AGAAALDH1A1PRKCA | |
| SCHEMBL27811640 | 0.91 | PARL (0.33) | KMT2AHPGDPARL | |
| SCHEMBL27560374 | 0.90 | KMT2A (0.47) | SMN1; SMN2KMT2AGAAALDH1A1PRKCA | |
| SCHEMBL27790887 | 0.84 | ALDH1A1 (0.38) | SMN1; SMN2KMT2AALDH1A1PARL | |
| SCHEMBL26687044 | 0.83 | TSHR (0.30) | — | |
| SCHEMBL22749331 | 0.80 | ALDH1A1 (0.34) | SMN1; SMN2KMT2AHPGDGAAALDH1A1 | |
| SCHEMBL28224401 | 0.77 | TDP1 (0.49) | KMT2AHPGDHTTGAAALDH1A1 | |
| SCHEMBL28576914 | 0.77 | PARL (0.36) | PARL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 61 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106117330-A | Restructuring desamidization gliadin antigen | 伯乐实验室公司 | 2016-11-16 | — | — | CN | claimed |
| CN-104254777-B | Recombinant deamidated gliadin antigens | 伯乐实验室公司 | 2016-08-24 | — | — | CN | claimed |
| CN-105121636-A | Non-replicating virus-derived particles and uses thereof | OTTAWA HOSPITAL RES INST | 2015-12-02 | — | — | CN | claimed |
| CN-104254777-A | Recombinant deamidated gliadin antigens | BIO RAD LABORATORIES | 2014-12-31 | — | — | CN | claimed |
| CN-101160326-B | Activated sialic acid derivatives for protein derivatization and conjugation | LIPOXEN TECHNOLOGIES LTD | 2013-04-10 | — | — | CN | claimed |
| CN-101421323-B | Loaded latex optical molecular imaging probes | CARESTREAM HEALTH INC | 2013-03-13 | — | — | CN | claimed |
| CN-101857792-B | Composite modified soybean protein adhesive as well as production method and application thereof | HEILONGJIANG SOYBEAN TECHNOLOGICAL DEV AND RES CT | 2012-01-18 | — | — | CN | claimed |
| CN-101068565-B | Compositions containing lipase, protease and amylase for treating pancreatic insufficiency | ALTUS PHARMACEUTICALS INC | 2010-11-17 | — | — | CN | claimed |
| CN-101857792-A | Composite modified soybean protein adhesive as well as production method and application thereof | HEILONGJIANG SOYBEAN TECHNOLOGICAL DEV AND RES CT | 2010-10-13 | — | — | CN | claimed |
| CN-101160326-A | Activated sialic acid derivatives for protein derivatization and conjugation | LIPOXEN TECHNOLOGIES LTD (GB) | 2008-04-09 | — | — | CN | claimed |
| CN-101068565-A | Compositions containing lipase, protease and amylase for treating pancreatic insufficiency | ALTUS PHARMACEUTICALS INC (US) | 2007-11-07 | — | — | CN | claimed |
| CN-118033110-A | Preparation method of antigen-coupled amino magnetic beads | 河北医陆生物科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| WO-2023093532-A1 | COMPOSITE GEL, PREPARATION METHOD, AND APPLICATION | 爱美客技术发展股份有限公司 | 2023-06-01 | — | — | WO | disclosed |
| CN-109890417-A | The treatment of cancer and/or prophylactic compositions | 东丽株式会社 | 2019-06-14 | — | — | CN | disclosed |
| CN-105246467-B | For stablizing the method for being encapsulated with the suspension of red blood cell of active constituent, suspension obtained | 爱瑞泰克药物公司 | 2018-11-27 | — | — | CN | disclosed |
| CN-101035563-A | Multimeric VLA-4 antagonists comprising polymer moieties | ELAN PHARMACEUTICAL INC (US) | 2007-09-12 | — | — | CN | disclosed |
| CN-1989152-A | Mussel bioadhesive | POSCO (KR) | 2007-06-27 | — | — | CN | disclosed |
| CN-1751251-A | Biomedical devices with antimicrobial coatings | JOHNSON & JOHNSON VISION CARE (US) | 2006-03-22 | — | — | CN | disclosed |
| CN-1174998-C | Peptide immunogens for the prevention and treatment of allergy | ��˹��ŵ�� | 2004-11-10 | — | — | CN | disclosed |
| CN-1213380-A | Peptide immunogens for the prevention and treatment of allergy | NOVARTIS AG (CH) | 1999-04-07 | — | — | CN | disclosed |